1Salib RJ Drae. ALLergicrhinitis:past,present and the future[J].Clinical Otolaryngology,2003,(04):291.doi:10.1046/j.1365-2273.2003.00706.x.
2Gorlic L,Geiger AM,GWifl AJ. Incidence of white spot fo:marion after bonding and banding[J].American Journal of Orthodontics,1982,(02):93-98.
3Bell WH. Surgical correction of dentofacialdeformities[M].Philadelphia:saunderCompany,1980.146-148.doi:10.1177/1078155208101097.
4boldogh I,Bacsi A,Choudhury B. ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation[J].Journal of Clinical Investigation,2005,(56):2169-2179.doi:10.1172/JCI24422.
5Djavid GE,Hassan Moeinzad. Prediction of arch perimeter changesdue to orthodontic treatment[J].Am J OrthodDentofacal Orthop,2005,(06):601-607.
6Keam SJ,Ploser GL. Rupatadine:A review of its use in the management of allergic disorders[J].Drugs,2007.457-474.
7G De Amici M,Murdaca G. Serum IL-17 levels are related with clinical severity in allergic rhinitis[J].Allergy,2009,(09):1375-1378.doi:10.1016/j.biopha.2008.08.005.
8Ohmori aise T,Ohshima E. Pharmacological,Pharmacoinetic and Clinical Properties of Olopatadine Hydrochloride,a New Antiallergic Drug[J].Japanese Journal of Pharmacology,2002.379-397.
9Ren Ru,Ckert Bloeing. IL-Preventsthe,Induetion of Allergen-Specifie T Cellsand ALL ergie Inflanunation InVivo[J].J The Journal,2005.5507-5515.
10Merlos M,Giral M,Balsa D. Rupatadine,a new potent,orally active dual antagonist of histamine and platelet-activating factor[J].J P harmacol Exp Ther,1977.114-121.
